DE60221795D1 - Orale zusammensetzungen von itraconazol und verfahren zu herstellung derselbigen - Google Patents

Orale zusammensetzungen von itraconazol und verfahren zu herstellung derselbigen

Info

Publication number
DE60221795D1
DE60221795D1 DE60221795T DE60221795T DE60221795D1 DE 60221795 D1 DE60221795 D1 DE 60221795D1 DE 60221795 T DE60221795 T DE 60221795T DE 60221795 T DE60221795 T DE 60221795T DE 60221795 D1 DE60221795 D1 DE 60221795D1
Authority
DE
Germany
Prior art keywords
itraconazole
acid
working solution
particles
coated particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60221795T
Other languages
English (en)
Other versions
DE60221795T2 (de
Inventor
Ranga Raju Namburi
John Elgin Kerr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stiefel Research Australia Pty Ltd
Stiefel Laboratories Inc
Original Assignee
Stiefel Research Australia Pty Ltd
Stiefel Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stiefel Research Australia Pty Ltd, Stiefel Laboratories Inc filed Critical Stiefel Research Australia Pty Ltd
Publication of DE60221795D1 publication Critical patent/DE60221795D1/de
Application granted granted Critical
Publication of DE60221795T2 publication Critical patent/DE60221795T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60221795T 2001-02-06 2002-02-01 Orale zusammensetzungen von itraconazol und verfahren zu herstellung derselbigen Expired - Fee Related DE60221795T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26665301P 2001-02-06 2001-02-06
US266653P 2001-02-06
US09/933,032 US6663897B2 (en) 2001-02-06 2001-08-20 Oral itraconazole formulations and methods of making the same
US933032 2001-08-20
PCT/NL2002/000080 WO2002062318A2 (en) 2001-02-06 2002-02-01 Oral itraconazole formulations and methods of making the same

Publications (2)

Publication Number Publication Date
DE60221795D1 true DE60221795D1 (de) 2007-09-27
DE60221795T2 DE60221795T2 (de) 2007-12-27

Family

ID=26951964

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60221795T Expired - Fee Related DE60221795T2 (de) 2001-02-06 2002-02-01 Orale zusammensetzungen von itraconazol und verfahren zu herstellung derselbigen

Country Status (9)

Country Link
US (1) US6663897B2 (de)
EP (1) EP1357899B1 (de)
JP (1) JP2004521897A (de)
AT (1) ATE369840T1 (de)
AU (1) AU2002233822A1 (de)
CA (1) CA2437372A1 (de)
DE (1) DE60221795T2 (de)
MX (1) MXPA03006980A (de)
WO (1) WO2002062318A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015239D0 (en) * 2000-06-21 2000-08-16 Biochemie Gmbh Organic compounds
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
US20040115266A1 (en) * 2002-02-01 2004-06-17 Namburi Ranga Raju Oral itraconazole formulations and methods of making the same
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US7446107B2 (en) 2002-02-15 2008-11-04 Transform Pharmaceuticals, Inc. Crystalline forms of conazoles and methods of making and using the same
EP1494998A2 (de) 2002-03-01 2005-01-12 University Of South Florida Mehrkomponenten festphasen enthaltend wenigstens einen pharmazeutischen wirkstoff
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
AU2003243354A1 (en) 2002-05-31 2003-12-19 Transform Pharmaceuticals, Inc. Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
CA2489984A1 (en) 2002-06-21 2003-12-31 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
WO2004012714A1 (en) * 2002-08-05 2004-02-12 Dsm Ip Assets B.V. Oral dosage forms of water insoluble drugs and methods of making the same
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US20050074494A1 (en) * 2003-10-06 2005-04-07 Xiu-Xiu Cheng Itraconazole immediate release formulation
US20050118265A1 (en) * 2003-11-28 2005-06-02 Anandi Krishnan Antifungal oral dosage forms and the methods for preparation
GB0612695D0 (en) * 2006-06-27 2006-08-09 Univ Gent Process for preparing a solid dosage form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791111A (en) 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
IT1263831B (it) 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
AU731704B2 (en) * 1996-06-28 2001-04-05 Schering Corporation Oral composition comprising a triazole antifungal compound
FR2758461A1 (fr) 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
RU2218153C2 (ru) * 1997-03-26 2003-12-10 Жансен Фармасетика Н.В. Драже, имеющее ядро, покрытое противогрибковым средством и полимером
KR100549095B1 (ko) * 1998-07-17 2006-02-06 얀센 파마슈티카 엔.브이. 항진균제 및 중합체로 코팅된 코어를 갖는 펠릿
AU767154B2 (en) 1998-11-20 2003-10-30 Skyepharma Canada Inc. Dispersible phospholipid stabilized microparticles
CN1156461C (zh) 1999-03-24 2004-07-07 R·P·希拉技术股份有限公司 改良的水溶性药物制剂
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
KR100331529B1 (ko) 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법

Also Published As

Publication number Publication date
EP1357899A2 (de) 2003-11-05
ATE369840T1 (de) 2007-09-15
JP2004521897A (ja) 2004-07-22
CA2437372A1 (en) 2002-08-15
WO2002062318A3 (en) 2002-11-21
MXPA03006980A (es) 2004-10-15
AU2002233822A1 (en) 2002-08-19
US20020150620A1 (en) 2002-10-17
WO2002062318A2 (en) 2002-08-15
DE60221795T2 (de) 2007-12-27
EP1357899B1 (de) 2007-08-15
US6663897B2 (en) 2003-12-16

Similar Documents

Publication Publication Date Title
DE60221795D1 (de) Orale zusammensetzungen von itraconazol und verfahren zu herstellung derselbigen
ATE358455T1 (de) Trockene hämostatische zusammensetzungen und verfahren zu ihrer herstellung
DE50110049D1 (de) Magnesium-ammonium-phosphat-zemente, deren herstellung und verwendung
DE60138362D1 (de) Bioadhäsive zusammensetzung
AR002720A1 (es) Proceso para preparar una composición oral sólida de olanzapina con subrecubrimiento de polímero y recubrimiento coloreado
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
DE69621523D1 (de) Verfahren zur herstellung einer pharmazeutischen formulierung
HUP9900467A2 (hu) Savval szemben labilis, omeprazolt tartalmazó gyógyászati készítmény, és eljárás előállítására
SE7611379L (sv) Antihypertensiva medel
CY1106015T1 (el) Ενα συμπυκνωμενο, υδατοδιαλυτο, κοκκωδες σκευασμα ρυθμιστη της φυτικης αναπτυξης και μεθοδοι χρησης και ιδιου
DE69906269D1 (de) Wässriges verfahren zur herstellung fester paroxetin-dispersionen
DE69132497D1 (de) Benzimidazolderivate, verfahren zu deren herstellung und deren anwendung
DK1442198T3 (da) Fremgangsmåde til opbrydning af en underjordisk formation ved brug af gelerende syrer
DE69905905D1 (de) Orale pharmazeutische zusammensetzung enthaltend einen wirkstoff mit antimykotischer wirkung und verfahren zu ihrer herstellung
SV2003000633A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
DE60102850T2 (de) Verfahren zur Herstellung von wässrigen Beschichtungszusammensetzungen
DE60134899D1 (de) Herstellung von Risperidon
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
PT992509E (pt) Novos derivados macrolidos
BR9912444A (pt) Composições particuladas tendo uma camada hidrossolúvel, polimerizada de enxerto, induzida por plasma e processo para preparar as mesmas
ES2058963T3 (es) Dihidropiridinas substituidas heterociclicamente, procedimiento para su fabricacion y su uso en medicamentos.
CY1105345T1 (el) Φαινυλαλκινια
NO20004919L (no) Fremgangsmåte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater
DE50205794D1 (de) Verfahren zur herstellung fester formulierungen von natrium-3-hydroxy-3-methylbutyrat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee